SG11202110615TA - Heterocyclic compounds and uses thereof - Google Patents
Heterocyclic compounds and uses thereofInfo
- Publication number
- SG11202110615TA SG11202110615TA SG11202110615TA SG11202110615TA SG11202110615TA SG 11202110615T A SG11202110615T A SG 11202110615TA SG 11202110615T A SG11202110615T A SG 11202110615TA SG 11202110615T A SG11202110615T A SG 11202110615TA SG 11202110615T A SG11202110615T A SG 11202110615TA
- Authority
- SG
- Singapore
- Prior art keywords
- heterocyclic compounds
- heterocyclic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962831665P | 2019-04-09 | 2019-04-09 | |
| PCT/US2020/027297 WO2020210375A1 (en) | 2019-04-09 | 2020-04-08 | Heterocyclic compounds and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202110615TA true SG11202110615TA (en) | 2021-10-28 |
Family
ID=72748693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110615TA SG11202110615TA (en) | 2019-04-09 | 2020-04-08 | Heterocyclic compounds and uses thereof |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11332473B2 (pt) |
| EP (1) | EP3952877A4 (pt) |
| JP (1) | JP2022526831A (pt) |
| KR (1) | KR20210150476A (pt) |
| CN (1) | CN113939296A (pt) |
| AU (1) | AU2020271837A1 (pt) |
| BR (1) | BR112021019703A2 (pt) |
| CA (1) | CA3136492A1 (pt) |
| CL (1) | CL2021002521A1 (pt) |
| EA (1) | EA202192746A1 (pt) |
| IL (1) | IL287026A (pt) |
| MX (1) | MX2021012418A (pt) |
| SG (1) | SG11202110615TA (pt) |
| WO (1) | WO2020210375A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11299493B2 (en) | 2017-10-09 | 2022-04-12 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
| WO2023280180A1 (zh) * | 2021-07-05 | 2023-01-12 | 微境生物医药科技(上海)有限公司 | 作为Wee-1抑制剂的稠环化合物 |
| CN117751122A (zh) * | 2021-08-11 | 2024-03-22 | 微境生物医药科技(上海)有限公司 | 作为Wee-1抑制剂的1,2-二氢-3H-吡唑[3,4-d]嘧啶-3-酮化合物 |
| WO2023045942A1 (zh) * | 2021-09-22 | 2023-03-30 | 微境生物医药科技(上海)有限公司 | 作为Wee-1抑制剂的1,2-二氢-3H-吡唑[3,4-d]嘧啶-3-酮化合物 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE427310T1 (de) | 2002-01-18 | 2009-04-15 | Kyorin Seiyaku Kk | Kondensierte bicyclische pyrimidinderivate |
| DE602004025803D1 (de) | 2003-06-06 | 2010-04-15 | Arexis Ab | Verwendung von kondensierten heterozyklischen verbindungen als scce-hemmern zur behandlung von hautzuständen |
| AU2005292314B2 (en) | 2004-09-29 | 2011-11-03 | Portola Pharmaceuticals, Inc. | Substituted 2H-1,3-benzoxazin-4(3H)-ones |
| AR060635A1 (es) | 2006-04-27 | 2008-07-02 | Banyu Pharma Co Ltd | Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer |
| CN101784551A (zh) | 2007-06-15 | 2010-07-21 | 万有制药株式会社 | 二环苯胺衍生物 |
| WO2009054332A1 (ja) * | 2007-10-23 | 2009-04-30 | Banyu Pharmaceutical Co., Ltd. | ピリドン置換ジヒドロピラゾロピリミジノン誘導体 |
| CA2745959A1 (en) | 2008-12-12 | 2010-06-17 | Msd K.K. | Dihydropyrimidopyrimidine derivatives |
| PT2477628E (pt) | 2009-09-15 | 2014-11-25 | Merck Sharp & Dohme | Preparação de formas de hemihidrato cristalino de dihidropirazolopirimidinona |
| US8796289B2 (en) | 2011-07-19 | 2014-08-05 | Abbvie Inc. | Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases |
| US9181239B2 (en) | 2011-10-20 | 2015-11-10 | Abbvie Inc. | Pyridopyrimidinone inhibitors of kinases |
| US9718821B2 (en) | 2012-02-23 | 2017-08-01 | Abbvie Inc. | Pyridopyrimidinone inhibitors of kinases |
| ME02925B (me) | 2012-11-28 | 2018-04-20 | Merck Sharp & Dohme | Kompozicije i postupci za liječenje kancera |
| GB201306610D0 (en) | 2013-04-11 | 2013-05-29 | Almac Discovery Ltd | Pharmaceutical compounds |
| WO2015019037A1 (en) | 2013-08-05 | 2015-02-12 | Almac Discovery Limited | Pharmaceutical compounds |
| GB201322602D0 (en) | 2013-12-19 | 2014-02-05 | Almac Discovery Ltd | Pharmaceutical compounds |
| CA3003737C (en) | 2015-11-01 | 2021-09-14 | The Regents Of The University Of Colorado, A Body Corporate | Wee1 kinase inhibitors and methods of making and using the same |
| GB201612092D0 (en) | 2016-07-12 | 2016-08-24 | Almac Discovery Ltd | Pharmaceutical compounds |
| GB201612095D0 (en) | 2016-07-12 | 2016-08-24 | Almac Discovery Ltd | Pharmaceutical compounds |
| KR102030886B1 (ko) | 2016-09-23 | 2019-10-10 | 재단법인 대구경북첨단의료산업진흥재단 | 신규한 이미다졸일 피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 |
| US10703759B2 (en) | 2016-11-16 | 2020-07-07 | Impact Therapeutics, Inc | 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones |
| WO2018133829A1 (zh) | 2017-01-23 | 2018-07-26 | 南京明德新药研发股份有限公司 | 作为Wee1抑制剂的1,2-二氢-3H-吡唑[3,4-d]嘧啶-3-酮衍生物 |
| GB201703881D0 (en) | 2017-03-10 | 2017-04-26 | Almac Discovery Ltd | Pharmaceutical compounds |
| CN108623615B (zh) * | 2017-03-23 | 2022-12-13 | 上海迪诺医药科技有限公司 | 吡唑[3,4-d]嘧啶-3-酮的大环衍生物、其药物组合物及应用 |
| CA3058457A1 (en) | 2017-03-31 | 2018-10-04 | Seattle Genetics, Inc. | Combinations of chk1- and wee1 - inhibitors |
| CN110914277B (zh) | 2017-07-10 | 2022-08-09 | 上海瑛派药业有限公司 | 咪唑并[1,2-b]嘧啶并[4,5-d]哒嗪-5(6H)-酮类化合物及其应用 |
| AU2018312448B2 (en) * | 2017-08-01 | 2022-09-15 | Recurium Ip Holdings, Llc | 1, 2 - dihydro- 3h- pyrazolo [3, 4 - d] pyrimidin -3 - one analogs |
| WO2019037678A1 (zh) | 2017-08-24 | 2019-02-28 | 上海迪诺医药科技有限公司 | 吡唑并[3,4-d]嘧啶-3-酮衍生物、其药物组合物及应用 |
| US11299493B2 (en) * | 2017-10-09 | 2022-04-12 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
| AU2018347307A1 (en) | 2017-10-09 | 2020-04-23 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
| CN109810111B (zh) | 2017-11-20 | 2023-10-27 | 上海医药集团股份有限公司 | 一种吡唑酮并嘧啶类化合物、其制备方法及应用 |
| WO2019134539A1 (zh) | 2018-01-05 | 2019-07-11 | 四川科伦博泰生物医药股份有限公司 | 二氢吡唑酮并嘧啶类化合物及其制备方法和用途 |
| WO2019165204A1 (en) * | 2018-02-23 | 2019-08-29 | Newave Pharmaceutical Inc. | 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidine-3-one compounds as inhibitors of wee-1 kinase |
| WO2019169065A2 (en) | 2018-02-28 | 2019-09-06 | The Regents Of The University Of Colorado, A Body Corporate | Wee1 kinase inhibitors and methods of treating cancer using the same |
| JP7300460B2 (ja) * | 2018-03-09 | 2023-06-29 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | 置換１，２－ジヒドロ－３Ｈ－ピラゾロ［３，４－ｄ］ピリミジン－３－オン |
| WO2020210381A1 (en) | 2019-04-09 | 2020-10-15 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
| WO2020210383A1 (en) | 2019-04-09 | 2020-10-15 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
| US20220162229A1 (en) | 2019-04-09 | 2022-05-26 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
| US20220220115A1 (en) | 2019-04-09 | 2022-07-14 | Nuvation Bio Inc. | Heterocyclic compounds and uses thereof |
-
2020
- 2020-04-08 WO PCT/US2020/027297 patent/WO2020210375A1/en unknown
- 2020-04-08 KR KR1020217036088A patent/KR20210150476A/ko unknown
- 2020-04-08 BR BR112021019703A patent/BR112021019703A2/pt not_active Application Discontinuation
- 2020-04-08 EP EP20787951.1A patent/EP3952877A4/en not_active Withdrawn
- 2020-04-08 CN CN202080040846.1A patent/CN113939296A/zh active Pending
- 2020-04-08 JP JP2021559854A patent/JP2022526831A/ja active Pending
- 2020-04-08 CA CA3136492A patent/CA3136492A1/en active Pending
- 2020-04-08 US US16/843,713 patent/US11332473B2/en active Active
- 2020-04-08 AU AU2020271837A patent/AU2020271837A1/en not_active Abandoned
- 2020-04-08 MX MX2021012418A patent/MX2021012418A/es unknown
- 2020-04-08 EA EA202192746A patent/EA202192746A1/ru unknown
- 2020-04-08 SG SG11202110615TA patent/SG11202110615TA/en unknown
-
2021
- 2021-09-28 CL CL2021002521A patent/CL2021002521A1/es unknown
- 2021-10-06 IL IL287026A patent/IL287026A/en unknown
-
2022
- 2022-05-12 US US17/743,061 patent/US20230118115A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021012418A (es) | 2021-11-12 |
| BR112021019703A2 (pt) | 2021-12-14 |
| IL287026A (en) | 2021-12-01 |
| KR20210150476A (ko) | 2021-12-10 |
| EP3952877A1 (en) | 2022-02-16 |
| EP3952877A4 (en) | 2022-12-14 |
| JP2022526831A (ja) | 2022-05-26 |
| CA3136492A1 (en) | 2020-10-15 |
| AU2020271837A1 (en) | 2021-11-18 |
| CL2021002521A1 (es) | 2022-04-29 |
| EA202192746A1 (ru) | 2021-12-29 |
| US20200325142A1 (en) | 2020-10-15 |
| US20230118115A1 (en) | 2023-04-20 |
| US11332473B2 (en) | 2022-05-17 |
| CN113939296A (zh) | 2022-01-14 |
| WO2020210375A1 (en) | 2020-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202001340B (en) | Heterocyclic compound and use thereof | |
| ZA202106304B (en) | Heterocyclic compound and use thereof | |
| EP3694861A4 (en) | HETEROCYCLIC COMPOUNDS AND THEIR USES | |
| IL285178A (en) | compounds and their use | |
| EP3663281A4 (en) | HETEROCYCLIC COMPOUND AND ITS APPLICATION | |
| EP3816153A4 (en) | HETEROCYCLIC COMPOUND AND ITS USE | |
| EP3694509A4 (en) | HETEROCYCLIC COMPOUNDS AND THEIR USES | |
| GB201803568D0 (en) | Novel compounds and uses | |
| IL285177A (en) | compounds and their use | |
| IL287026A (en) | Heterocyclic compounds and their uses | |
| IL289617A (en) | Heterocyclic compounds | |
| IL289595A (en) | Heterocyclic compounds | |
| IL286497A (en) | compounds and their use | |
| ZA202105752B (en) | Haloallylamine compounds and application thereof | |
| IL277502A (en) | Compounds and uses for them | |
| ZA201908107B (en) | Heterocyclic compound and composition containing same | |
| EP3952875A4 (en) | HETEROCYCLIC COMPOUNDS AND USES THEREOF | |
| IL291499A (en) | Azaquinoline compounds and their uses | |
| IL284764A (en) | compounds and their uses | |
| IL276912A (en) | Heterocyclic compound and its use | |
| IL279483A (en) | Cyanotriazole compounds and their uses | |
| EP3952876A4 (en) | HETEROCYCLIC COMPOUNDS AND USES THEREOF | |
| IL285118A (en) | compounds and their uses | |
| EP3568137A4 (en) | HETEROCYCLIC COMPOUNDS AND USE OF SUCH COMPOUNDS | |
| EP3952878A4 (en) | HETEROCYCLIC COMPOUNDS AND USES THEREOF |